cysteine has been researched along with Hepatitis in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (61.90) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Gatbonton-Schwager, T; Joshi, T; Kensler, TW; Srinivasan, H; Suzuki, T; Wakabayashi, N; Yagishita, Y; Yamamoto, M | 1 |
| Béchereau, F; Breuillé, D; Denis, P; Glomot, F; Papet, I; Serrant, P; Vidal, K | 1 |
| HARRIS, AD; POLLOCK, MR; WILSON, C | 1 |
| Ichibangase, T; Imai, K; Koike, K; Koshiyama, A; Moriya, K; Yazawa, I | 1 |
| Deiss, D; Manns, MP; Strassburg, CP; Vogel, A | 1 |
| Dafforn, TR; Foreman, RC; Lomas, DA; Mahadeva, R; Parfrey, H; Ravenhill, NA; Zhou, A | 1 |
| TRUTSCHEL, W | 1 |
| BEHR, J | 1 |
| HOHNLOSER, E | 1 |
| SCHOLTHOLT, J | 1 |
| FILIPPI, D; TEDESCHI, GG | 1 |
| FREITAS, PA | 1 |
| MEHES, J; MOLNAR, Z; VARGA, F | 1 |
| LINDNER, H | 1 |
| Mitsuyoshi, H; Nakashima, T; Okanoue, T; Sumida, Y | 1 |
| Abraham, SC; Adams, LA; Angulo, P; Brandhagen, D; Torgerson, H | 1 |
| Wang, JT | 1 |
| Narazaki, R; Otagiri, M | 1 |
| Cortizas, JL; Franco, M; Rocha, A; Salom, R | 1 |
| Gerhold, WM; Mandel, EE | 1 |
| Alexander, M; Kludas, M | 1 |
1 review(s) available for cysteine and Hepatitis
| Article | Year |
|---|---|
[Treatment of nonalcoholic steatohepatitis (NASH)].
Topics: Cysteine; Diet; Drug Combinations; Fatty Liver; Glycine; Hepatitis; Humans; Insulin Resistance; Liver Transplantation; Obesity; Oleanolic Acid; Oxidative Stress; Ursodeoxycholic Acid; Vitamin E | 2004 |
1 trial(s) available for cysteine and Hepatitis
| Article | Year |
|---|---|
[A double-blind study of strong neominophagen-C in treating chronic hepatitis].
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Cysteine; Double-Blind Method; Drug Combinations; Female; Glycine; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrhizic Acid; Hepatitis; Humans; Male; Oleanolic Acid; Plants, Medicinal | 1984 |
19 other study(ies) available for cysteine and Hepatitis
| Article | Year |
|---|---|
A Point Mutation at C151 of
Topics: Animals; Cysteine; Cytoprotection; Hepatitis; Kelch-Like ECH-Associated Protein 1; Mice; Mice, Knockout; NF-E2-Related Factor 2; Oleanolic Acid; Point Mutation; Signal Transduction | 2023 |
Long-term cysteine fortification impacts cysteine/glutathione homeostasis and food intake in ageing rats.
Topics: Aging; Animals; Anorexia; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Appetite Regulation; Cysteine; Dietary Supplements; Energy Intake; Enteritis; Glutathione; Hepatitis; Homeostasis; Inflammation Mediators; Intestinal Mucosa; Intestine, Small; Liver; Male; Oxidative Stress; Rats, Wistar | 2014 |
Diet in the treatment of infective hepatitis; therapeutic trial of cysteine and variation of fat-content.
Topics: Cysteine; Diet; Hepatitis; Hepatitis A; Humans; Jaundice | 1946 |
Liquid chromatographic separation of proteins derivatized with a fluorogenic reagent at cysteinyl residues on a non-porous column for differential proteomics analysis.
Topics: Animals; Chromatography, Reverse-Phase; Cysteine; Fluorescent Dyes; Hepatitis; Mice; Mice, Transgenic; Mitochondria, Liver; Mitochondrial Proteins; Oxadiazoles; Porosity; Proteomics; Sulfonamides; Tandem Mass Spectrometry | 2011 |
A novel AIRE mutation in an APECED patient with candidiasis, adrenal failure, hepatitis, diabetes mellitus and osteosclerosis.
Topics: Adrenal Insufficiency; AIRE Protein; Amino Acid Substitution; Base Sequence; Cysteine; Diabetes Mellitus; Exons; Frameshift Mutation; Hepatitis; Heterozygote; History, 15th Century; Humans; Male; Osteosclerosis; Polyendocrinopathies, Autoimmune; Radiography; Threonine; Transcription Factors | 2003 |
Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease.
Topics: alpha 1-Antitrypsin; Animals; Binding Sites; Carcinoma, Hepatocellular; Chymotrypsin; Crystallography, X-Ray; Cysteine; Fibrosis; Glycine; Hepatitis; Hepatocytes; Hydrogen-Ion Concentration; Models, Molecular; Mutation; Oocytes; Phenylalanine; Polymers; Potassium Chloride; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Recombinant Proteins; Temperature; Threonine; Time Factors; Xenopus | 2003 |
[Homocysteine-thiolactone, cysteine and fructose therapy of acute and chronic hepatitis].
Topics: Cysteine; Fructose; Hepatitis; Hepatitis A; Hepatitis, Chronic; Homocysteine; Humans; Propionates | 1957 |
[Treatment of hepatitis with sulfhydryl combinations (reducdyn)].
Topics: Cysteine; Fructose; Hepatitis; Hepatitis A; Sulfhydryl Compounds; Thiophenes | 1958 |
[Recent viewpoints on the treatment of acute viral hepatitis with special reference to the behavior of serum proteins].
Topics: Blood Proteins; Communicable Diseases; Cysteine; Fructose; Hepatitis; Hepatitis A; Humans; Lactones | 1961 |
[Behavior of serum bilirubin and serum enzymes in acute viral hepatitis during therapy with Reducdyn].
Topics: Amino Acids; Bilirubin; Cysteine; Fructose; Hepatitis; Hepatitis A; Humans; Lactate Dehydrogenases; Oxidoreductases; Phosphoric Monoester Hydrolases; Thiophenes; Transaminases | 1962 |
[RESEARCH ON THE TOXICITY OF GAMMA-L-GLUTAMYL-S-METHYL-L-CYSTEINE].
Topics: Animals; Chemical and Drug Induced Liver Injury; Cysteine; Glutathione; Hepatitis; Hepatitis A; Kidney; Mice; Pharmacology; Rabbits; Toxicology | 1963 |
[THERAPY OF ACUTE AND CHRONIC HEPATIC DISEASES WITH THE DRUG ASSOCIATION, HOMOCYSTEINE-THIOLACTONE, CYSTEINE AND FRUCTOSE].
Topics: Chemical and Drug Induced Liver Injury; Cysteine; Fructose; Hepatitis; Hepatitis A; Hepatitis B virus; Homocysteine; Humans; Lactones; Liver Cirrhosis; Liver Diseases | 1963 |
[THE LIVER PROTECTIVE EFFECT OF CYSTEINE, HOMOCYSTEINE THIOLACTONE AND N-ACETYLHOMOCYSTEINE THIOLACTONE IN EXPERIMENTAL LIVER DAMAGE].
Topics: Alcohols; Aspartate Aminotransferases; Benzene; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cysteine; Hepatitis; Homocysteine; Lactones; Liver Function Tests; Rats; Research; Sulfobromophthalein; Thiophenes; Toxicology | 1963 |
[The therapy of hepatitis epidemica with reducdyn. A collective therapeutic comparison].
Topics: Communicable Diseases; Cysteine; Fructose; Hepatitis; Hepatitis A; Humans; Thiophenes | 1960 |
The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Topics: Adult; Aged; Aspartic Acid; Cysteine; Fatty Liver; Female; Genetic Predisposition to Disease; Glucose Intolerance; Hemochromatosis; Hepatitis; Heterozygote; Histidine; Homozygote; Humans; Iron Overload; Liver Cirrhosis; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prospective Studies; Risk Factors; Tyrosine | 2006 |
Covalent binding of a bucillamine derivative with albumin in sera from healthy subjects and patients with various diseases.
Topics: Butyrates; Cysteine; Diabetes Mellitus; Hepatitis; Humans; Kidney Failure, Chronic; Protein Binding; Renal Dialysis; Rheumatic Diseases; Serum Albumin; Sulfhydryl Compounds | 1997 |
[Clinical test of a "polyvalent liver protector" on various diffuse liver diseases of prolonged evolution].
Topics: Adult; Cysteine; Female; Hepatitis; Humans; Liver Function Tests; Male; Methionine; Middle Aged | 1969 |
Plasma fibrin-stabilizing factor: acquired deficiency in various disorders.
Topics: Acute Disease; Adult; Aged; Anemia, Macrocytic; Anemia, Sickle Cell; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Cysteine; Factor XIII; Fibrinogen; Hepatitis; Hot Temperature; Humans; Leukemia; Liver Cirrhosis; Liver Neoplasms; Lupus Erythematosus, Systemic; Lymphoma; Methods; Middle Aged; Myeloproliferative Disorders; Neoplasm Metastasis; Prothrombin Time; Uremia | 1969 |
[Collagen synthesis inhibition by D-penicillamine in patients with chronic, aggressive hepatitis].
Topics: Chelating Agents; Chronic Disease; Collagen; Connective Tissue; Cysteine; Female; Hepatic Encephalopathy; Hepatitis; Humans; Middle Aged; Penicillamine; Prednisolone | 1969 |